why choose us

First received: October 26, 2023

Clinical Trial: Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Study Status: Completed

Recruit Status: RECRUITING

Condition: Meningococcal Infection

Study Type: INTERVENTIONAL


Official Title: A Phase I/II, Randomized, Descriptive, Safety and Immunogenicity Study to Assess Pentavalent Meningococcal ABCYW Vaccine Formulations in Adults (18 to 25 Years of Age) and Adolescents (10 to 17 Y

Brief Summary: The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents.The study duration will be up to 12 months for all participants.

Read more